Last updated on March 2017

Patients needed for migraine study "Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine"


Brief description of study

Patients needed for migraine study "Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine"

Detailed Study Description

This research study is being conducted for patients experiencing migraines. This study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (25 and 50 mg) compared to placebo for the acute treatment of a single migraine attack.

Clinical Study Identifier: TX148072

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.